“Freeze-dried” describes a processing step, not a shelf-life guarantee. A lyophilized peptide powder can still change during storage, especially if its container, residual moisture or transport conditions differ from the material used in a stability study. Buyers need evidence tied to the proposed material and pack.
Start with the claim being made
Ask whether the date on an offer is an expiry date, a retest date or an internal planning estimate. An expiry statement says the product is expected to meet defined criteria through a stated period under specified conditions. A retest date instead identifies when the material should be assessed again before use. These terms should not be swapped casually. Where no supported period exists, request the supplier’s current evidence and agree how your own quality team will handle the material.
What a useful stability package connects
Material and batch
Confirm the peptide identity, supplied form and batch relationship of the samples tested. If a process or formulation changed after the study, ask whether the earlier evidence still applies. The test panel should connect to the attributes that matter in the agreed specification, such as identity, relevant impurities, appearance and moisture where appropriate.
Container and handling
The study should identify the container-closure system and storage conditions used. A different vial, stopper, fill amount or secondary barrier may change exposure to moisture or light. Check whether shipment conditions have been considered; a storage instruction on a label cannot repair an unsupported packaging assumption.
Time points and interpretation
Ask for the time points assessed, methods, acceptance criteria and an explanation of any trend. A single passing COA at release demonstrates release status, not future stability. Reconstitution or downstream formulation can introduce a new stability question that the dry-powder data do not answer.
Keep finished-product guidance in its proper scope
ISO/TR 18811:2018 gives guidelines for stability testing of cosmetic products and explains why a manufacturer must justify its chosen design. It is not a ready-made test protocol or expiry period for every raw peptide. The FDA’s cosmetics shelf-life guidance likewise places responsibility for determining a cosmetic product’s shelf life on the manufacturer. An ingredient supplier’s powder data and the brand’s finished-formula data serve different decisions.
Questions to put in the purchase file
- Which exact material, batches and commercial pack are covered?
- What attributes were tested, by which methods and against which limits?
- What storage and transport instructions follow from the evidence?
- Is the printed date an expiry date or a retest date?
- What happens if the container or manufacturing process changes?
Our packaging guide covers the container conversation; the quality page explains how to request batch documents. Ask for the evidence applicable to your quoted material rather than relying on a generic powder photograph.
Frequently asked questions
Is every lyophilized peptide stable at room temperature?
No general room-temperature claim follows from lyophilization. The answer depends on the particular material, packaging and supporting data.
Can a current COA establish a two-year shelf life?
No. A release COA reports a batch’s tested state at a point in time. A shelf-life statement needs relevant stability evidence and defined conditions.
Does dry-powder stability cover a reconstituted solution?
Usually this is a separate assessment because the material, container and exposure conditions change after reconstitution.
The storage statement you accept should point back to evidence for the material and pack you are buying.